- Victory Square Health received FDA permission to commence marketing, sales and distribution under EUA for Safetest 15 Minute Rapid Test in the United States on October 9, 2020.
- The Safetest 15 Minute Covid-19 Rapid Test has a 96.6% Sensitivity
- Over 7.8 million Covid-19 cases and 217,000 deaths reported in the United States as of October 9, 2020
- This FDA permission under EUA for the Safetest 15 Minute Rapid Test is in addition to the Elisa Test permission issued by the FDA (under EUA) on August 25, 2020
- Safetest Covid-19™ Rapid Test can confirm whether one is currently infected with the virus causing Covid-19 or whether one was infected before and was unaware of the infection
- The Company’s application for the Safetest 15 Minute Covid-19 Rapid Test is currently under review by Health Canada
VANCOUVER, British Columbia, Oct. 13, 2020 (GLOBE NEWSWIRE) — Victory Square Health Inc.(“VS Health″ or the “Company“)